Physician profile
Eric Jason Graham
NPI 1558462218
$15,167.55
in general payments reported to CMS, 2019-2025
11 companies · $2,686 in 2025
The $2,686 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $4,508 · 2021: $857 · 2022: $3,299 · 2023: $3,399 · 2024: $63.13 · 2025: $2,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,643 · Consulting Fee: $1,370 · Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,642.52 |
| Consulting Fee | $1,369.69 |
| Food and Beverage | $136.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $12,988.34 | 2020-2025 | |
| Mirus, LLC | $1,442.12 | 2021-2022 | |
| Globus Medical, INC. | $298.78 | 2019 | |
| Smith+Nephew, INC. | $206.25 | 2021 | |
| Djo, LLC | $86.24 | 2024-2025 | Cmf |
| Ethicon INC. | $40.10 | 2020 | |
| Republic Spine | $33.00 | 2024 | Dark Star |
| Providence Medical Technology, INC. | $26.66 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.77 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $14.97 | 2019 | |
| Medtronic USA, INC. | $14.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.